Literature DB >> 9653165

The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.

H Soto1, W Wang, R M Strieter, N G Copeland, D J Gilbert, N A Jenkins, J Hedrick, A Zlotnik.   

Abstract

We cloned the mouse homologue of the chemokine receptor CXCR3, which is located in mouse chromosome X. We screened a large panel of chemokines for their ability to induce a calcium flux in mouse CXCR3-transfected cells and identified a new ligand for this receptor, the recently reported CC chemokine 6Ckine. This represents an example of a CC chemokine, which binds to a CXC chemokine receptor. Like other ligands of this receptor, 6Ckine has angiostatic properties. 6Ckine is known to chemoattract T cells. In line with this, CXCR3 is expressed preferentially in Th1 cells and in lymphoid organs of the IL-10(-/-) mouse that develops chronic colitis. Its ability to attract T cells as well as its angiostatic properties suggest that 6Ckine may be an effective anti-tumor agent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9653165      PMCID: PMC20954          DOI: 10.1073/pnas.95.14.8205

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Development and applications of a molecular genetic linkage map of the mouse genome.

Authors:  N G Copeland; N A Jenkins
Journal:  Trends Genet       Date:  1991-04       Impact factor: 11.639

Review 2.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 3.  Structure-activity relationships of chemokines.

Authors:  I Clark-Lewis; K S Kim; K Rajarathnam; J H Gong; B Dewald; B Moser; M Baggiolini; B D Sykes
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

4.  Cloning of human genes encoding novel G protein-coupled receptors.

Authors:  A Marchese; J M Docherty; T Nguyen; M Heiber; R Cheng; H H Heng; L C Tsui; X Shi; S R George; B F O'Dowd
Journal:  Genomics       Date:  1994-10       Impact factor: 5.736

5.  Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells.

Authors:  G Tosato; C Sgadari; K Taga; K D Jones; S E Pike; A Rosenberg; J M Sechler; I T Magrath; L A Love; K Bhatia
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

6.  Murine chromosomal location of four class III POU transcription factors.

Authors:  K B Avraham; B C Cho; D Gilbert; H Fujii; K Okamoto; T Shimazaki; T Ito; H Shoji; Y Wakamatsu; H Kondoh
Journal:  Genomics       Date:  1993-10       Impact factor: 5.736

7.  Lymphotactin: a cytokine that represents a new class of chemokine.

Authors:  G S Kelner; J Kennedy; K B Bacon; S Kleyensteuber; D A Largaespada; N A Jenkins; N G Copeland; J F Bazan; K W Moore; T J Schall
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

8.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.

Authors:  A D Luster; S M Greenberg; P Leder
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.

Authors:  A L Angiolillo; C Sgadari; D D Taub; F Liao; J M Farber; S Maheshwari; H K Kleinman; G H Reaman; G Tosato
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

10.  IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.

Authors:  A D Luster; P Leder
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  48 in total

Review 1.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 2.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro.

Authors:  V C Asensio; J Maier; R Milner; K Boztug; C Kincaid; M Moulard; C Phillipson; K Lindsley; T Krucker; H S Fox; I L Campbell
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 4.  Neuronal chemokines: versatile messengers in central nervous system cell interaction.

Authors:  A H de Haas; H R J van Weering; E K de Jong; H W G M Boddeke; K P H Biber
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

Review 5.  Chemokines as mediators of angiogenesis.

Authors:  Borna Mehrad; Michael P Keane; Robert M Strieter
Journal:  Thromb Haemost       Date:  2007-05       Impact factor: 5.249

Review 6.  Chemokines as mediators of tumor angiogenesis and neovascularization.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Exp Cell Res       Date:  2010-10-30       Impact factor: 3.905

7.  CCL21 Chemokine Therapy for Lung Cancer.

Authors:  Sherven Sharma; Li Zhu; Minu K Srivastava; Marni Harris-White; Min Huang; Jay M Lee; Fran Rosen; Gina Lee; Gerald Wang; Valerie Kickhoefer; Leonard H Rome; Felicita Baratelli; Maie St John; Karen Reckamp; Seok Chul-Yang; Sven Hillinger; Robert Strieter; Steven Dubinett
Journal:  Int Trends Immun       Date:  2013-01

Review 8.  Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.

Authors:  C Caux; S Ait-Yahia; K Chemin; O de Bouteiller; M C Dieu-Nosjean; B Homey; C Massacrier; B Vanbervliet; A Zlotnik; A Vicari
Journal:  Springer Semin Immunopathol       Date:  2000

9.  Anatomical profiling of G protein-coupled receptor expression.

Authors:  Jean B Regard; Isaac T Sato; Shaun R Coughlin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

10.  Regulated expression of CCL21 in the prostate tumor microenvironment inhibits tumor growth and metastasis in an orthotopic model of prostate cancer.

Authors:  Nazita Yousefieh; Suzanne M Hahto; Amber L Stephens; Richard P Ciavarra
Journal:  Cancer Microenviron       Date:  2009-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.